1. Home
  2. STC vs RAPP Comparison

STC vs RAPP Comparison

Compare STC & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stewart Information Services Corporation

STC

Stewart Information Services Corporation

HOLD

Current Price

$65.44

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$37.03

Market Cap

1.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
STC
RAPP
Founded
1893
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
1994
2024

Fundamental Metrics

Financial Performance
Metric
STC
RAPP
Price
$65.44
$37.03
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$81.00
$48.50
AVG Volume (30 Days)
136.8K
270.5K
Earning Date
04-22-2026
05-08-2026
Dividend Yield
3.00%
N/A
EPS Growth
55.17
24.34
EPS
0.55
N/A
Revenue
$2,921,636,000.00
N/A
Revenue This Year
$13.62
N/A
Revenue Next Year
$7.13
N/A
P/E Ratio
$120.16
N/A
Revenue Growth
17.32
N/A
52 Week Low
$56.39
$10.57
52 Week High
$78.61
$42.27

Technical Indicators

Market Signals
Indicator
STC
RAPP
Relative Strength Index (RSI) 46.55 50.67
Support Level $62.45 $33.55
Resistance Level $66.92 $40.81
Average True Range (ATR) 1.65 2.30
MACD 0.08 -0.00
Stochastic Oscillator 51.83 54.61

Price Performance

Historical Comparison
STC
RAPP

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments: Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.

Share on Social Networks: